{
    "title": "Eli Lilly advances experimental coronavirus treatment with eye toward approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8576145/Eli-Lilly-raises-2020-profit-forecast-second-quarter-profit-beats.html",
    "date": "2020-07-30",
    "keywords": [
        "company",
        "antibody",
        "treatment",
        "carl",
        "therapy",
        "midstage",
        "efficacy",
        "year",
        "reward",
        "covid19",
        "pandemic",
        "profit",
        "thursday",
        "coronavirus",
        "approval",
        "lycov555",
        "biotech",
        "abcellera",
        "testing",
        "finalstage",
        "trial",
        "quarter",
        "risk",
        "versus",
        "something",
        "analyst",
        "navin",
        "urgency",
        "decision",
        "data",
        "safety",
        "officer",
        "daniel",
        "skovronsky",
        "conference",
        "call",
        "spending",
        "part",
        "manufacturing",
        "vaccine",
        "drugmaker",
        "shanghai",
        "junshi",
        "class",
        "biotechnology",
        "street",
        "hit",
        "revenue",
        "disruption",
        "spread",
        "infection",
        "executive",
        "david",
        "forecast",
        "range",
        "confidence",
        "half",
        "share",
        "reporting",
        "bengaluru",
        "york",
        "editing",
        "dasgupta",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}